-
How Scar Tissue Affects Mesothelioma Surgery After Chemotherapy
A new study by physicians at Leiden University Medical Center in the Netherlands is helping doctors better understand how scar tissue formed during mesothelioma treatment affects whether surgery is possible and how well it works. These findings could help doctors better choose the right patients for surgery and improve patient outcomes.
-
MSK Finds Why Mesothelioma Tumors Resist Immunotherapy
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have uncovered a previously unknown reason why mesothelioma tumors become resistant to immunotherapy. At the same time, they’ve identified several promising strategies to reverse that resistance. Their discovery could significantly improve treatment outcomes for patients with the rare and aggressive asbestos-related cancer.
-
Global Forum to Bring Together International Mesothelioma Experts
Mesothelioma experts, patients, families, caregivers, healthcare professionals, and researchers from around the world will come together on July 2, 2026, for the inaugural Global Mesothelioma Education Forum. The free international webinar has been organized by Thoracic Oncology Frontiers in collaboration with leading mesothelioma organizations worldwide. It will cover the latest developments in mesothelioma research, treatment,…
-
South Carolina Supreme Court Allows Mesothelioma Claims Against English Asbestos Company
One of the most frustrating issues faced by mesothelioma and asbestos-related lung cancer victims seeking justice has been the inability to seek compensation from foreign asbestos companies. In the past, these companies have relied on a series of strategies to keep their assets out of reach of the American justice system, but a recent decision…
-
Talc Now Cited in 4 in 10 Mesothelioma Lawsuits
In a recently published report, the highly respected Washington D.C. consultancy KCIC revealed that talc exposure was cited in 4 out of 10 mesothelioma lawsuits filed in 2025. This represents a significant increase and radical shift in asbestos disease litigation — talc was cited in just 1 in 6 claims in 2021. In a related…
-
Federal Funding Cut Shutters Libby Mesothelioma Clinic
The Center for Asbestos Related Disease (CARD) has served the Libby, Montana community for more than 20 years, providing advocacy and care for patients diagnosed with mesothelioma and other asbestos-related diseases. But the clinic will close its doors at the end of August after its federal grant funding was not renewed. This closes a chapter…
-
Asbestos Found in Children’s Toys at Walmart Extends Global Crisis
Healthcare professionals and mesothelioma advocates are sounding the alarm after more than 121,000 children’s squeeze toys were found to contain sand contaminated with tremolite asbestos. The U.S. Consumer Product Safety Commission has recalled Orb Funkee-brand sand-filled, monkey-shaped squeeze toys that were sold at Walmart and Ollie’s Bargain Outlet stores nationwide between February 2025 and April…
-
Stanford Offering New Minimally Invasive PITAC Procedure for Mesothelioma
In what is a first in North America, Northern California’s Stanford Medicine has announced that thoracic surgeon Dr. Leah Backhus performed the first PITAC procedure for mesothelioma. The groundbreaking minimally invasive operation offers real hope for patients who are not candidates for more aggressive surgery.
-
Mesothelioma Treatment Receives Second Orphan Drug Designation
Two months after receiving Orphan Drug Designation from the U.S. Food and Drug Administration (FDA), Orion Pharma’s investigational drug ODM-212 has received the same benefit from the European Commission. This significant development means the treatment will receive significant incentives on both sides of the Atlantic, offering real hope for its promising new approach to treating…
-
UK Court Approves Group Litigation for Mesothelioma & Ovarian Cancer Claims Against J&J
As is true in the United States, thousands of United Kingdom citizens who’ve been diagnosed with mesothelioma and ovarian cancer blame asbestos in Johnson & Johnson’s talc-based baby powder for their illnesses. In what has now become the largest product liability case in British history, the country’s High Court has approved a Group Litigation Order…
-
Company Fined $500,000 for Asbestos Violations and Mesothelioma Risk
A redevelopment firm that knowingly exposed workers to the risk of mesothelioma, lung cancer, and asbestosis has been ordered to pay a $500,000 criminal fine and to serve two years of probation. Applied Partners LLC, admitted to starting demolition work at a former automotive plant in Saginaw, Michigan, without first completing asbestos remediation. The federal…
-
AI Performance in Measuring Mesothelioma Tumors Will Transform Treatment Decisions
According to a study published in The Lancet Oncology, physicians and researchers at the Netherlands Cancer Institute have developed an Artificial Intelligence model that outperforms human doctors in evaluating treatment response in pleural mesothelioma. This breakthrough means that disease progression can be detected five weeks earlier than the currently used criteria. It will offer patients…
-
J&J Ordered to Pay $32 Million to Family of Baby Powder Mesothelioma Victim
A Los Angeles jury has ordered consumer giant Johnson & Johnson to pay $32 million in damages to the family of Maria Lozano, a woman who died from mesothelioma. The woman was diagnosed with the rare, asbestos-related disease after using the company’s talc-based baby powder on herself and her children for decades.
-
Will New Tumor Injection Be a Breakthrough for Mesothelioma Patients?
All too often, traditional mesothelioma treatments fail to provide the hoped-for benefit, leaving patients with limited options. But according to results presented at the American Society of Clinical Oncology’s annual meeting in Chicago, a new triple-action cancer injection under development may offer new hope. The drug, called amivantamab, has produced what researchers described as “unprecedentedly…
-
Research Shows Mesothelioma Deaths Rising Despite Declining Rates
Newly published research has revealed a troubling paradox in mesothelioma trends across the United States. While age-standardized mesothelioma rates have declined by roughly one-third since 1990, the actual number of people diagnosed with mesothelioma increased by nearly 30%, and annual deaths have continued climbing. This means that the rare, asbestos-related disease is evolving rather than…
-
Cosmetic Talc Company Creates First-of-its-Kind $20 Million Asbestos Trust
A Texas bankruptcy judge recently confirmed cosmetics ingredient supplier Miyoshi America Inc.’s Chapter 11 plan to establish a $20 million trust addressing mesothelioma and asbestos-related personal injury claims. The approach represents the first-ever prepackaged talc reorganization in U.S. bankruptcy history, with 99% of current mesothelioma and talc claimants voting to accept the groundbreaking settlement.
-
Appeals Court Affirms Retrial Over J&J Baby Powder Cervical Cancer
Five years after a Georgia jury delivered a win to Johnson & Johnson in a case filed by the daughter of a cervical cancer victim, a Georgia Court of Appeals panel has unanimously upheld a trial judge’s decision to grant a new trial. The decision offers new hope to the woman’s family, as well as…
-
United Kingdom Clinical Trial Will Test Proton Beam Therapy for Mesothelioma
Mesothelioma is one of the most aggressive, most deadly forms of cancer, and researchers around the world have dedicated themselves to finding a way to improve outcomes for those impacted by this asbestos-related disease. Recently, the University College London (UCL) and University College London Hospitals NHS Foundation Trust announced that they will be conducting a…
-
Cholesterol Drug’s Immunotherapy Boost May Benefit Mesothelioma Patients
A new study published in JAMA Network Open gives hope that a specific class of cholesterol-lowering drugs may boost the effectiveness of immunotherapy in ways that could benefit mesothelioma patients. Researchers found that patients with certain cancers treated with immune checkpoint inhibitors—the same class of drugs FDA-approved for mesothelioma—who also took PCSK9 inhibitors had a…
-
Did Johnson & Johnson Disclose Asbestos Mesothelioma Risk to FDA?
In an ongoing trial blaming consumer giant Johnson & Johnson of causing three women’s ovarian cancer, the jury was shown a video deposition in which a former J&J toxicologist said he found no evidence his employer had provided the FDA with a report that “unmistakably” found asbestos in the company’s talc. The question has been…
